Valuation: Quest Laboratories Limited

Market Cap 1.71B 17.88M 15.32M 14.33M 13.12M 24.62M 24.95M 169M 66.03M 859M 67.14M 65.68M 2.84B P/E 2024 *
-
P/E 2025 12.4x
Enterprise Value 1.52B 15.89M 13.61M 12.73M 11.66M 21.87M 22.16M 150M 58.67M 764M 59.65M 58.35M 2.53B EV / Sales 2024 *
-
EV / Sales 2025 1.43x
Free-Float
99%
Yield 2024 *
-
Yield 2025 -
1 day-1.21%
1 week-6.12%
Current month-3.81%
1 month-7.64%
3 months-20.51%
6 months-30.03%
Current year-22.03%
1 week 85.15
Extreme 85.15
93
1 month 85.15
Extreme 85.15
96.75
Current year 85.15
Extreme 85.15
152.6
1 year 84
Extreme 84
152.6
3 years 75.15
Extreme 75.15
196.8
5 years 75.15
Extreme 75.15
196.8
10 years 75.15
Extreme 75.15
196.8
Manager TitleAgeSince
Chief Executive Officer 59 2023-12-31
Director of Finance/CFO 38 2023-12-31
Compliance Officer - 2025-09-02
Director TitleAgeSince
Chairman 59 2023-12-31
Director/Board Member 31 2021-03-04
Director/Board Member 72 2024-01-09
Change 5-day change 1-year change 3-year change Capi.($)
-1.21%-6.12%-13.93% - 14.7M
+0.88%+6.38%+76.40%+126.75% 1,119B
+1.07%+3.80%+50.73%+62.78% 651B
+1.20%+6.21%+25.81%+78.74% 468B
+1.02%+5.77%+43.63%+48.43% 374B
+0.85%+4.07%+24.97%+40.58% 302B
+1.26%+6.81%+2.27%+14.41% 259B
+1.88%+5.81%+49.57%+70.53% 238B
+1.59%+2.09%-17.33%-52.62% 208B
+1.87%+5.61%+27.32%+91.38% 181B
Average +1.04%+3.86%+26.94%+53.44% 379.99B
Weighted average by Cap. +1.14%+5.09%+44.26%+72.65%

Financials

2024 2025
Net sales 826M 8.63M 7.39M 6.92M 6.33M 11.88M 12.04M 81.71M 31.87M 415M 32.4M 31.7M 1.37B 1.04B 10.87M 9.31M 8.71M 7.97M 14.96M 15.16M 103M 40.13M 522M 40.8M 39.91M 1.73B
Net income 101M 1.05M 904K 846K 774K 1.45M 1.47M 9.99M 3.9M 50.71M 3.96M 3.88M 168M 136M 1.42M 1.21M 1.14M 1.04M 1.95M 1.98M 13.43M 5.24M 68.15M 5.32M 5.21M 225M
Net Debt 49.37M 516K 442K 414K 379K 711K 720K 4.89M 1.91M 24.8M 1.94M 1.9M 82.04M -191M -1.99M -1.71M -1.6M -1.46M -2.75M -2.78M -18.88M -7.36M -95.85M -7.49M -7.33M -317M
Logo Quest Laboratories Limited
Quest Laboratories Limited is engaged in the business of manufacturing pharmaceutical formulations across a broad spectrum, including antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory medications, diabetes treatments, antidepressants, and more. It produces a variety of products, comprising ethical drugs, generic drugs, and over-the-counter drugs (OTC). These products are available in various forms, such as tablets, liquid orals, oral dry powders, oral powders (ORS), ointments, and external liquids. The tablets include Cetirizine Hydrochloride Tablet IP 10 mg, Zinc Sulphate Dispersible Tablet IP, Diclofenac Sodium Tablet BP, and others. It offers dry syrup and suspension, such as Ferrous Sulphate & Folic Acid Syrup, Albendazole Suspension IP, Zinc Oral Solution USP, Alpha Amilase & Pepsine, Sucralfate Suspension, and others. Its ointments include Silver Sulphadiazine Cream IP, Diclofenac Diethylamino IP Gel, and Povidone Iodine Ointment USP.
Employees
-
Date Price Change Volume
26-08-21 ₹85.85 -1.21% 13,200
26-08-20 ₹86.90 -2.36% 6,000
26-08-19 ₹89.00 +1.08% 4,800
26-08-18 ₹88.05 0.00% 7,200
26-08-17 ₹88.05 -3.72% 33,600
  1. Stock Market
  2. Stocks
  3. QUESTLAB Stock